May 9 (Reuters)-
Xebio Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 250.60 242.43 264.31 131.12
(+3.4 pct) (+1.3 pct) (+5.5 pct) (+4.7 pct)
Operating 7.01 4.20 7.22 3.66
(+66.6 pct) (-49.5 pct) (+3.1 pct) (-10.8 pct)
Recurring 7.62 5.41 7.72 3.88
(+40.9 pct) (-41.5 pct) (+1.3 pct) (-8.6 pct)
Net
Net 971 mln 2.59 974 mln 540 mln
(-62.5 pct) (-52.0 pct) (+0.2 pct) (-73.2 pct)
EPS 22.61 yen 58.62 yen 22.66 yen 12.56 yen
EPS Diluted 22.46 yen 58.31 yen
Ann Div 32.50 yen 30.00 yen 35.00 yen
-Q2 Div 15.00 yen 15.00 yen 17.50 yen
-Q4 Div 17.50 yen 15.00 yen 17.50 yen
NOTE - Xebio Holdings Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=8281.T